NEW YORK (GenomeWeb News) – NanoString Technologies said after the close of the market on Tuesday that revenues for its second quarter rose 22 percent year over year.

The Seattle-based company, which went public in late June, raising $47.0 million in net proceeds, reported revenues of $7.2 million for the three months ended June 30, compared to $5.9 million a year ago, and beating the average Wall Street estimate of $6.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.